Abbott Laboratories

    Jurisdiction
    United States
    LEI
    HQD377W2YR662HK5JX27
    ISIN
    US0028241000 (ABT)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    InsiderPie Expert Score
    trending_up 53 / 100
    Worse than peer group:
    59 / 100
    Fair value (Benjamin Graham formula)
    €42.68 158.3% overvalued
    Financial strength (Piotroski F-Value)
    7 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    1 / 7

    Profile

    Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €36.99B
    Gross margin
    56.1%
    EBIT
    €6.49B
    EBIT margin
    17.5%
    Net income
    €11.99B
    Net margin
    32.4%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €41.46B +12.1% €8.56B -28.7%
    €44.51B +7.4% €9.43B +10.2%
    €47.72B +7.2% €10.39B +10.2%

    Dividends

    Last dividend amount
    $0.59
    Ex date
    Payment date
    Dividend payout ratio
    28.4%

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Boudreau Philip P EVP AND CFO -5.6K $134.55 -$746.75K

    Congress transactions

    Name Transaction date Value
    Rick Larsen October 16, 2025 $1.00K–$15.00K
    Richard McCormick September 17, 2025 $1.00K–$15.00K
    Julie Johnson September 11, 2025 $1.00K–$15.00K
    Thomas Kean August 20, 2025 $1.00K–$15.00K
    Lisa McClain August 13, 2025 $1.00K–$15.00K

    Earnings Calls

    Latest earnings call: July 17, 2025

    Investor transactions

    Name Shares Value Last change Change type
    Ray Dalio 73K $9.66M -119K Sell
    Nancy Zevenbergen 21K $2.86M +195 Buy

    Add to watchlist

    Notifications